157 related articles for article (PubMed ID: 23710167)
1. The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Gastroenterol Res Pract; 2013; 2013():430438. PubMed ID: 23710167
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Oncol Rep; 2013 Jul; 30(1):91-8. PubMed ID: 23615658
[TBL] [Abstract][Full Text] [Related]
3. Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
J Gastrointestin Liver Dis; 2013 Jun; 22(2):173-81. PubMed ID: 23799216
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
J Cancer; 2013; 4(6):502-13. PubMed ID: 23901350
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma.
Chen YS; Huang KH; Wang PM; Chuang CH; Yong CC; Liu YW; Huang PY; Yao CC; Lin YP; Tsai MC
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208582
[No Abstract] [Full Text] [Related]
6. Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection:
Jia HD; Liang L; Li C; Wu H; Wang H; Liang YJ; Zhou YH; Gu WM; Fan XP; Zhang WG; Chen TH; Chen ZY; Zhong JH; Lau WY; Pawlik TM; Diao YK; Xu QR; Shen F; Zhang CW; Huang DS; Yang T
Front Oncol; 2021; 11():700228. PubMed ID: 34395268
[TBL] [Abstract][Full Text] [Related]
7. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C viral load predicts tumor recurrence after curative resection of hepatocellular carcinoma regardless of the genotype of hepatitis C virus.
Shindoh J; Hasegawa K; Takemura N; Omichi K; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Kokudo N
Hepatol Int; 2014 Jan; 8(1):112-20. PubMed ID: 26202412
[TBL] [Abstract][Full Text] [Related]
9. Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas.
Hashimoto M; Tashiro H; Kobayashi T; Kuroda S; Hamaoka M; Ohdan H
Langenbecks Arch Surg; 2017 Aug; 402(5):745-755. PubMed ID: 28534136
[TBL] [Abstract][Full Text] [Related]
10. Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma.
Li Z; Zhang C; Lou C; Yan F; Mao Y; Hong X; Zhang Y
Oncol Lett; 2013 Jul; 6(1):239-245. PubMed ID: 23946811
[TBL] [Abstract][Full Text] [Related]
11. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
12. Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Arimoto A; Kita R; Kimura T
Anticancer Res; 2013 May; 33(5):2211-9. PubMed ID: 23645778
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
14. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.
Tohra S; Duseja A; Taneja S; Kalra N; Gorsi U; Behera A; Kaman L; Dahiya D; Sahu S; Sharma B; Singh V; Dhiman RK; Chawla Y
J Clin Exp Hepatol; 2021; 11(6):682-690. PubMed ID: 34866847
[TBL] [Abstract][Full Text] [Related]
15. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival and recurrence after curative resection for hepatocellular carcinoma in patients with chronic hepatitis C virus infection: a multicenter observational study from China.
Zhu H; Xing H; Yu B; Yan WT; Zhang CW; Guan MC; Zhou YH; Wang H; Zhang WG; Zhang YM; Li J; Wang Y; Chen TH; Zeng YY; Lau WY; Liang L; Li C; Yang T
HPB (Oxford); 2020 Dec; 22(12):1793-1802. PubMed ID: 32456976
[TBL] [Abstract][Full Text] [Related]
17. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
[TBL] [Abstract][Full Text] [Related]
18. Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation.
Ryu T; Takami Y; Wada Y; Tateishi M; Matsushima H; Yoshitomi M; Mikagi K; Saitsu H
Hepatol Int; 2018 Mar; 12(2):149-157. PubMed ID: 29488056
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrence.
Ohki T; Sato K; Kondo M; Goto E; Sato T; Kondo Y; Akamatsu M; Sato S; Yoshida H; Koike Y; Obi S
J Viral Hepat; 2021 Nov; 28(11):1597-1603. PubMed ID: 34312954
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
